2026 340B Program Update – 340B Rebate Model RFI Comments Due and Manufacturers Continue Restricting 340B Pricing

The 340B Rebate Pilot: Voluntary for Manufacturers, Costly for 340B Covered Entities

Supreme Court Halts Nationwide Injunctions with Major Implications for Ongoing Litigation

DOJ Civil Division Refocuses Affirmative Enforcement Priorities

DOJ Announces Intent to Use False Claims Act To Target Diversity and DEI Initiatives

SCOTUS Rejects Defense-Friendly Scienter Standard In Schutte Opinion

DOJ Continues to Target Lab Sales Arrangements and Ordering Practices

False Claims Act: Appellate Court Deepens Circuit Split in Favor of Healthcare Defendants

False Claims Act Recoveries 2022

DOJ Strengthens Efforts to Combat Corporate Crime with Increased Focus on Individual Culpability and Self-Disclosure

Health Care Reimbursement and Payor Dispute Update

SCOTUS Sides with 340B Hospitals and Denies CMS’s Attempt to Cut Reimbursement for 340B Drugs